Atomera Inc
NASDAQ:ATOM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Atomera Inc
NASDAQ:ATOM
|
US |
|
Chemomab Therapeutics Ltd
NASDAQ:CMMB
|
IL |
|
M
|
Mensch und Maschine Software SE
OTC:MSHHF
|
DE |
Income Statement
Earnings Waterfall
Atomera Inc
Income Statement
Atomera Inc
| Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||||||||
| Interest Expense |
1
|
2
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+91%
|
0
N/A
|
0
+19%
|
0
+28%
|
0
-9%
|
1
+86%
|
1
-2%
|
1
-2%
|
0
-13%
|
0
-56%
|
0
-70%
|
0
+567%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
-5%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
-97%
|
0
N/A
|
0
N/A
|
1
+5 400%
|
1
+3%
|
1
+13%
|
1
+3%
|
0
-80%
|
0
-10%
|
0
-60%
|
0
-22%
|
0
+71%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+100%
|
0
+70%
|
0
+41%
|
0
+21%
|
0
-3%
|
0
-7%
|
0
-19%
|
0
-24%
|
0
-69%
|
0
+700%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
-28%
|
0
N/A
|
0
N/A
|
0
+3%
|
0
-97%
|
0
N/A
|
0
N/A
|
1
+5 120%
|
1
-3%
|
1
0%
|
1
+4%
|
0
-98%
|
0
+158%
|
(0)
N/A
|
(0)
-469%
|
(0)
-55%
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(3)
|
(5)
|
(8)
|
(10)
|
(12)
|
(13)
|
(14)
|
(13)
|
(13)
|
(12)
|
(13)
|
(13)
|
(14)
|
(14)
|
(14)
|
(14)
|
(14)
|
(14)
|
(14)
|
(15)
|
(15)
|
(15)
|
(16)
|
(16)
|
(16)
|
(17)
|
(17)
|
(18)
|
(19)
|
(20)
|
(20)
|
(21)
|
(21)
|
(20)
|
(20)
|
(19)
|
(20)
|
(20)
|
(21)
|
(21)
|
|
| Selling, General & Administrative |
(2)
|
(3)
|
(5)
|
(6)
|
(7)
|
(8)
|
(8)
|
(7)
|
(7)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(9)
|
(9)
|
(9)
|
(9)
|
(8)
|
(8)
|
(9)
|
(9)
|
(9)
|
|
| R&D |
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(10)
|
(10)
|
(11)
|
(11)
|
(12)
|
(13)
|
(12)
|
(12)
|
(11)
|
(11)
|
(11)
|
(12)
|
(12)
|
(12)
|
|
| Operating Income |
(3)
N/A
|
(5)
-55%
|
(8)
-53%
|
(10)
-25%
|
(12)
-17%
|
(13)
-16%
|
(14)
-4%
|
(13)
+6%
|
(13)
+3%
|
(12)
+3%
|
(12)
-1%
|
(13)
-5%
|
(14)
-4%
|
(14)
-4%
|
(14)
+2%
|
(14)
+1%
|
(14)
+1%
|
(14)
0%
|
(14)
-3%
|
(15)
-5%
|
(15)
0%
|
(15)
+0%
|
(15)
-4%
|
(16)
-1%
|
(16)
-3%
|
(17)
-5%
|
(17)
-3%
|
(18)
-2%
|
(19)
-7%
|
(20)
-5%
|
(20)
-4%
|
(21)
-2%
|
(21)
+1%
|
(20)
+4%
|
(19)
+3%
|
(19)
0%
|
(20)
-2%
|
(20)
-3%
|
(21)
-5%
|
(21)
+1%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(3)
|
(4)
|
(5)
|
(3)
|
(2)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(7)
N/A
|
(9)
-40%
|
(13)
-45%
|
(13)
+5%
|
(14)
-8%
|
(15)
-8%
|
(14)
+6%
|
(13)
+6%
|
(13)
+4%
|
(12)
+4%
|
(12)
-1%
|
(13)
-5%
|
(13)
-3%
|
(14)
-3%
|
(13)
+3%
|
(13)
+1%
|
(13)
-1%
|
(14)
-1%
|
(14)
-4%
|
(15)
-6%
|
(15)
+0%
|
(15)
+0%
|
(15)
-4%
|
(16)
-2%
|
(16)
-3%
|
(17)
-5%
|
(17)
-2%
|
(17)
-1%
|
(18)
-5%
|
(19)
-4%
|
(19)
-2%
|
(20)
-2%
|
(20)
+1%
|
(19)
+4%
|
(18)
+2%
|
(18)
0%
|
(19)
-2%
|
(19)
-3%
|
(20)
-5%
|
(20)
+1%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(7)
|
(9)
|
(13)
|
(13)
|
(14)
|
(15)
|
(14)
|
(13)
|
(13)
|
(12)
|
(12)
|
(13)
|
(13)
|
(14)
|
(13)
|
(13)
|
(13)
|
(14)
|
(14)
|
(15)
|
(15)
|
(15)
|
(15)
|
(16)
|
(16)
|
(17)
|
(17)
|
(17)
|
(18)
|
(19)
|
(19)
|
(20)
|
(20)
|
(19)
|
(18)
|
(18)
|
(19)
|
(19)
|
(20)
|
(20)
|
|
| Net Income |
(7)
N/A
|
(9)
-40%
|
(13)
-45%
|
(13)
+5%
|
(14)
-8%
|
(15)
-8%
|
(14)
+6%
|
(13)
+6%
|
(13)
+4%
|
(12)
+4%
|
(12)
-1%
|
(13)
-5%
|
(13)
-3%
|
(14)
-3%
|
(13)
+3%
|
(13)
+1%
|
(13)
-1%
|
(14)
-1%
|
(14)
-4%
|
(15)
-6%
|
(15)
+0%
|
(15)
+0%
|
(15)
-4%
|
(16)
-2%
|
(16)
-3%
|
(17)
-5%
|
(17)
-2%
|
(17)
-1%
|
(18)
-5%
|
(19)
-4%
|
(19)
-2%
|
(20)
-2%
|
(20)
+1%
|
(19)
+4%
|
(18)
+2%
|
(18)
0%
|
(19)
-2%
|
(19)
-3%
|
(20)
-5%
|
(20)
+1%
|
|
| EPS (Diluted) |
-0.58
N/A
|
-5.66
-876%
|
-1.8
+68%
|
-2.22
-23%
|
-1.13
+49%
|
-1.21
-7%
|
-1.14
+6%
|
-1.08
+5%
|
-1.04
+4%
|
-1
+4%
|
-1.01
-1%
|
-1.02
-1%
|
-0.9
+12%
|
-0.89
+1%
|
-0.81
+9%
|
-0.84
-4%
|
-0.8
+5%
|
-0.75
+6%
|
-0.72
+4%
|
-0.79
-10%
|
-0.67
+15%
|
-0.65
+3%
|
-0.68
-5%
|
-0.7
-3%
|
-0.72
-3%
|
-0.75
-4%
|
-0.76
-1%
|
-0.75
+1%
|
-0.79
-5%
|
-0.77
+3%
|
-0.77
N/A
|
-0.8
-4%
|
-0.75
+6%
|
-0.73
+3%
|
-0.66
+10%
|
-0.68
-3%
|
-0.62
+9%
|
-0.63
-2%
|
-0.68
-8%
|
-0.65
+4%
|
|